Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
Drugs Made In America Acquisition II Corp. (DMII) Ownership Overview
3.41%
Mutual Funds
40.79% Other Institutional Investors
0.08% ETFs
55.72% Public Companies and
Individual Investors
The ownership structure of Drugs Made In America Acquisition II Corp. (DMII) stock is a mix of institutional, retail, and individual investors. Approximately 44.28% of the company’s stock is owned by Institutional Investors, and 55.72% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $7425000 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $10890000 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $4950000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Drugs Made In America Acquisition II Corp. (DMII)?
Currently, no data Available
What percentage of Drugs Made In America Acquisition II Corp. (DMII) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.79% of Drugs Made In America Acquisition II Corp. (DMII) stock is held by institutional investors.
What percentage of Drugs Made In America Acquisition II Corp. (DMII) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.72% of Drugs Made In America Acquisition II Corp. (DMII) stock is held by retail investors.
Who owns the most shares of Drugs Made In America Acquisition II Corp. (DMII)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.